Clinical Trial Update: Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing survival and autonomy in elderly relapsed diffuse large B-cell lymphoma patients treated with Rituximab plus chemotherapy or Rituximab p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)
• Rituximab (rituximab)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Chemotherapy, Diffuse Large B-Cell Lymphoma (DLBCL), Nos | Phase 2 | Status: UNKNOWN